China’s Telitacicept Sets New Benchmark in gMG Treatment with Landmark Phase 3 Results

Impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: 泰爱®...

April 09, 2025 | Wednesday | News
Rhythm Pharmaceuticals to Announce Topline Results from Phase 3 TRANSCEND Trial of Setmelanotide in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc., a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendoc...

April 07, 2025 | Monday | News
AES Cleanroom Technology Launches Omni ASCENT at INTERPHEX 2025 to Redefine Modular Utility Integration

AES Cleanroom Technology, a leader in modular cleanroom solutions, has officially launched Omni ASCENT at INTERPHEX 2025. The next-generation Off-Site Ma...

April 04, 2025 | Friday | News
ICP DAS-BMP Showcases Medical-Grade TPU for Ureteral Stents at CMEF 2025

ICP DAS-BMP (Biomedical Polymers), a committed Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is excited to...

March 25, 2025 | Tuesday | News
Harvard Bioscience to Showcase Cutting-Edge Innovations at 2025 Society of Toxicology Conference

Harvard Bioscience, Inc. will present its latest product innovations at the Society of Toxicology (SOT) conference, further advancing preclinical research ...

February 25, 2025 | Tuesday | News
GC Biopharma Presents Promising Updates on LSD Pipeline at WORLD Symposium 2025

GC Biopharma, a South Korean biopharmaceutical company, announced that it presented development updates on its LSD (lysosomal storage disorder) pipelines a...

February 11, 2025 | Tuesday | News
Convergent Therapeutics Announces Promising Clinical Trial Updates for CONV01-α at ASCO Genitourinary Cancers Symposium 2025

Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment o...

February 11, 2025 | Tuesday | News
Kodiak Sciences to Present Novel Glaucoma Treatment at Glaucoma 360 New Horizons Forum 2025

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to tre...

February 05, 2025 | Wednesday | News
Swiss Business Hub India Strengthens Swiss-Indian Ties at World Economic Forum 2025 in Davos

The Swiss Business Hub India once again played a pivotal role at the sidelines of the World Economic Forum 2025 in Davos, fostering connections between s...

January 27, 2025 | Monday | News
Serum Institute of India CEO Adar Poonawalla Advocates for Equitable Healthcare Access at World Economic Forum 2025 in Davos

At the prestigious World Economic Forum 2025, Adar Poonawalla, CEO of Serum Institute of India Pvt. Ltd., joined the influential panel ‘Health and ...

January 27, 2025 | Monday | News
Abyssinia Biosciences and Cordance Medical Partner to Explore Focused Ultrasound for Alzheimer's Diagnosis and Treatment

Abyssinia Biosciences and Cordance Medical announced  that they have entered into a collaborative agreement to explore focused ultrasound in diagnosti...

January 24, 2025 | Friday | News
CG Pharmaceuticals Presents Promising Results for Ivaltinostat in Metastatic Pancreatic Cancer at ASCO GI Symposium

CG Pharmaceuticals (CG Pharma), a clinical biopharmaceutical company located in the San Francisco Bay Area, was established as an independent entity i...

January 24, 2025 | Friday | News
ALX Oncology to Host Virtual Event on Updated Data from ASPEN-06 Trial of Evorpacept in HER2-Positive Advanced Gastric Cancer

ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing ther...

January 23, 2025 | Thursday | News
Solid Biosciences Advances Toward Transformative Genetic Medicines with Expanded Pipeline and New Clinical Milestones

Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines fo...

January 17, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close